FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy

FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy

Submitted by admin on January 20, 2023 - 10:26am
Source: 
Pharmaceutical Business Review
News Tags: 
Evaxion Biotech
EVX-01
FDA
fast track
personalized medicine
Headline: 
FDA grants fast track designation to Evaxion Biotech’s personalized cancer therapy
snippet: 


The US Food and Drug Administration (FDA) has granted fast track designation to Evaxion Biotech’s personalized cancer therapy, EVX-01, in combination with KEYTRUDA.

Do Not Allow Advertisers to Use My Personal information